TIF Shares Position Statement Urging Health Authorities to Identify Thalassemia/SCD Patients as High Risk of COVID-19
April 21, 2020 – TIF has created a Position Statement in which it encourages national health authorities worldwide to include patients with thalassemia and sickle cell disease in the group of patients considered high risk/vulnerable to COVID-19. It is hoped that such a request will lead to increased vigilance and prevention measures on behalf of these patients in treatment centers. Further details can be found in the Position Statement linked below.